StartseiteMCPWorkbenchSkills
StartseiteWorkbenchBenachrichtigungenMein Bereich
llms.txt · MCP-AnleitungDatenschutz · Nutzungsbedingungen · Supportv1.8.3
  1. Startseite
  2. /Reaktion

Trimethylaluminum → HCID 178489760, Verbindung

HRID 1911421
Drucken

Reaktionsgleichung

Reaktionsgleichung von HRID 1911421
[N:1]1([C:8]2[CH:18]=[CH:17][C:11]([C:12]([O:14]CC)=O)=[CH:10][CH:9]=2)[CH2:7][CH2:6][CH2:5][NH:4][CH2:3][CH2:2]1.[CH3:19][O:20][C:21]1[CH:22]=[C:23]([CH2:29][CH2:30][C:31]2[CH:32]=[C:33]([NH2:36])[NH:34][N:35]=2)[CH:24]=[C:25]([O:27][CH3:28])[CH:26]=1.C[Al](C)C>C1(C)C=CC=CC=1>[N:1]1([C:8]2[CH:9]=[CH:10][C:11]([C:12]([NH:36][C:33]3[NH:34][N:35]=[C:31]([CH2:30][CH2:29][C:23]4[CH:24]=[C:25]([O:27][CH3:28])[CH:26]=[C:21]([O:20][CH3:19])[CH:22]=4)[CH:32]=3)=[O:14])=[CH:17][CH:18]=2)[CH2:7][CH2:6][CH2:5][NH:4][CH2:3][CH2:2]1
KomponentenVersuchsvorschriftAufarbeitungQuellen und NachweiseNotizen zur Reaktion

Komponenten

5

Edukt 3

HCID 16682925TrimethylaluminumHCID 18425301Ethyl 4-(1,4-diazepan-1-yl)benzoateHCID 178489815HCID 178489815, Verbindung

Produkt 1

HCID 178489760HCID 178489760, VerbindungAusbeute 2,7 %

Reagenzien, Katalysatoren, Lösungsmittel 1

HCID 1140TolueneLösungsmittel

Versuchsvorschrift

4-(1,4-diazepan-1-yl)-N-[5-[2-(3,5-dimethoxyphenyl)ethyl]-2H-pyrazol-3-yl]benzamide was prepared following the procedure as outlined for Example 99, starting from ethyl 4-(1,4-diazepan-1-yl)benzoate (0.497 g, 2 mmol) and 5-[2-(3,5-dimethoxyphenyl)ethyl]-2H-pyrazol-3-amine (0.495 g, 2.00 mmol) and 2M trimethylaluminium (2.50 mL, 5.0 mmol) in toluene (10 ml). The crude product was purified by silica column chromatography, eluting with a gradient of 0 to 10% 2.5 M ammonia MeOH in DCM. Fractions containing the product were evaporated to dryness and further purified by preparative HPLC, using decreasingly polar mixtures of water (containing 1% NH3) and MeCN as eluents. Fractions containing the desired compound were evaporated to dryness to afford the title compound (0.024 g, 2.67%) as a white solid.

Aufarbeitung

  1. custom4-(1,4-diazepan-1-yl)-N-[5-[2-(3,5-dimethoxyphenyl)ethyl]-2H-pyrazol-3-yl]benzamide was prepared
  2. customThe crude product was purified by silica column chromatography
  3. washeluting with a gradient of 0 to 10% 2.5 M ammonia MeOH in DCM
  4. additionFractions containing the product
  5. customwere evaporated to dryness
  6. customfurther purified by preparative HPLC
  7. additionFractions containing the desired compound
  8. customwere evaporated to dryness

Quellen und Nachweise

ORD-Eintrag
ord-9c728a501340436faded9f9a51548025
Quelldatensatz
uspto-grants-2013_12
DOI
10.6084/m9.figshare.5104873.v1
Patentnummer
US08604022B2

Notizen zur Reaktion

Auf dieser SeiteKomponentenVersuchsvorschriftAufarbeitungQuellen und NachweiseNotizen zur Reaktion